Nightingale Health Oyj

DB:7XE Stock Report

Market Cap: €189.5m

Nightingale Health Oyj Future Growth

Future criteria checks 2/6

Nightingale Health Oyj is forecast to grow earnings and revenue by 17.1% and 42.4% per annum respectively. EPS is expected to grow by 17.5% per annum. Return on equity is forecast to be -22.6% in 3 years.

Key information

17.1%

Earnings growth rate

17.5%

EPS growth rate

Healthcare earnings growth27.5%
Revenue growth rate42.4%
Future return on equity-22.6%
Analyst coverage

Low

Last updated27 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:7XE - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202717-12-14-71
6/30/202611-14-17-101
6/30/20257-17-17-111
6/30/20244-17-13-8N/A
3/31/20244-18N/AN/AN/A
12/31/20234-18-11-8N/A
9/30/20234-18-12-7N/A
6/30/20234-18-12-7N/A
3/31/20234-18-14-8N/A
12/31/20223-19-16-9N/A
9/30/20223-17-15-8N/A
6/30/20222-16-15-7N/A
3/31/20222-14-12-5N/A
12/31/20213-12-9-3N/A
9/30/20212-11-7-3N/A
6/30/20212-10-5-2N/A
3/31/20212-8-7-3N/A
12/31/20202-5-9-3N/A
9/30/20202-4-10-3N/A
6/30/20202-4-11-3N/A
6/30/20192-4-7-4N/A
6/30/20182-3N/AN/AN/A
6/30/20172-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7XE is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 7XE is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 7XE is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 7XE's revenue (42.4% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: 7XE's revenue (42.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 7XE is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y